Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Combined effect of hyperuricemia and overweight/obesity on the prevalence of hypertension among US adults: result from the National Health and Nutrition Examination Survey

Journal of Human Hypertension volume 28, pages 579–586 (2014)Cite this article

Subjects

Abstract

Hypertension is a large and growing public health problem worldwide. Hyperuricemia and overweight/obesity are two of the most important risk factors for hypertension. However, their combined effect on the risk of hypertension is not known. Participants aged 20 years and older from the National Health and Nutrition Examination Survey from 1999–2012 were used to evaluate the separate and combined effects of hyperuricemia and overweight/obesity on the risk of prevalent hypertension among different race, gender and age groups. Participants (31 473) were used to estimate separate and combined effects on the prevalence of hypertension. The overall prevalence of hypertension among adults with a combination of hyperuricemia and overweight/obesity (50.2%, 95% confidence interval (CI) 48.3–52.1%) was significantly higher than separate hyperuricemia (41.7%, 95% CI 37.2–46.2%) and overweight/obesity (30.6%, 95% CI 29.5–31.8%). The magnitude of odds ratio (OR) from the combination of hyperuricemia and overweight/obesity (OR=4.53, 95% CI 4.05–5.07) was significantly higher than both hyperuricemia (OR=2.62, 95% CI 2.07–3.32) and overweight/obesity (OR=2.08, 95% CI 1.89–2.30). Combined effect of hyperuricemia and overweight/obesity on the risk of hypertension is much stronger than any separate one. These data can provide important information for identification of target populations for future intervention and patient management.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Centers for Disease Control and Prevention (CDC). Vital signs: prevalence, treatment, and control of hypertension—United States, 1999–2002 and 2005-2008. MMWR 2011; 60: 103–108.

  2. Farley TA, Dalal MA, Mostashari F, Frieden TR . Deaths preventable in the US by improvements in use of clinical preventive services. Am J Prev Med 2010; 38: 600–609.

    Article  Google Scholar 

  3. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J . Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365: 217–223.

    Article  Google Scholar 

  4. Chockalingam A, Campbell NR, Fodor JG . Worldwide epidemic of hypertension. Can J Cardiol 2006; 22: 553–555.

    Article  Google Scholar 

  5. Mazzali M, Hughes J, Kim YG, Jefferson JA, Kang DH, Gordon KL et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101–1106.

    Article  CAS  Google Scholar 

  6. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure independent mechanism. Am J Physiol Renal Physiol 2002; 282: F991–F997.

    Article  CAS  Google Scholar 

  7. Johnson RJ, Feig DI, Herrera-Acosta J, Kang DH . Resurrection of uric acid as a causal risk factor in essential hypertension. Hypertension 2005; 45: 18–20.

    Article  CAS  Google Scholar 

  8. Mahomed FA . On chronic Bright’s disease, and its essential symptoms. Lancet 1879; 1: 399–401.

    Article  Google Scholar 

  9. Nagahama K, Inoue T, Iseki K, Touma T, Kinjo K, Ohya Y et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens Res 2004; 27: 835–841.

    Article  Google Scholar 

  10. Soletsky B, Feig DI . Uric acid reduction rectifies prehypertension in obese adolescents. Hypertension 2012; 60: 1148–1156.

    Article  CAS  Google Scholar 

  11. Kotchen TA . Obesity-related hypertension?: weighing the evidence. Hypertension 2008; 52: 801–802.

    Article  CAS  Google Scholar 

  12. Segal-Lieberman G, Rosenthal T . Animal models in obesity and hypertension. Curr Hypertens Rep 2013; 15: 190–195.

    Article  CAS  Google Scholar 

  13. Mangge H, Zelzer S, Puerstner P, Schnedl WJ, Reeves G, Postolache TT et al. Uric acid best predicts metabolically unhealthy obesity with increased cardiovascular risk in youth and adults. Obesity (Silver Spring) 2013; 21: E71–E77.

    Article  CAS  Google Scholar 

  14. Ishiro M, Takaya R, Mori Y, Takitani K, Kono Y, Okasora K et al. Association of uric acid with obesity and endothelial dysfunction in children and early adolescents. Ann Nutr Metab 2013; 62: 169–176.

    Article  CAS  Google Scholar 

  15. Krzystek-Korpacka M, Patryn E, Kustrzeba-Wojcicka I, Chrzanowska J, Gamian A, Noczynska A . The effect of a one-year weight reduction program on serum uric acid in overweight/obese children and adolescents. Clin Chem Lab Med 2011; 49: 915–921.

    CAS  PubMed  Google Scholar 

  16. Ogden CL, Carroll MD, Kit BK, Flegal KM . Prevalence of obesity in the United States, 2009–2010, NCHS data brief, no 82 National Center for Health Statistics: Hyattsville, MD, USA, 2012.

    Google Scholar 

  17. Viazzi F, Antolini L, Giussani M, Brambilla P, Galbiati S, Mastriani S et al. Serum uric acid and blood pressure in children at cardiovascular risk. Pediatrics 2013; 132: e93–e99.

    Article  Google Scholar 

  18. Komiya I, Yamada T, Takasu N, Asawa T, Akamine H, Yagi N et al. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system. J Hypertens 1997; 15: 65–72.

    Article  CAS  Google Scholar 

  19. Centers for Disease Control and Prevention (CDC). The Third National Health and Nutrition Examination Survey (NHANES III 1988–94) reference manuals and reports [CD-ROM]. National Center for Health Statistics: Hyattsville, MD, USA, 1996.

  20. Feig DI . Hyperuricemia and hypertension. Adv Chronic Kidney Dis 2012; 19: 377–385.

    Article  Google Scholar 

  21. Sundström J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS . Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005; 45: 28–33.

    Article  Google Scholar 

  22. Hollister LE, Overall JE, Snow HL . Relationship of obesity to serum triglyceride, cholesterol, and uric acid and to plasma-glucose levels. Am J Clin Nutr 1967; 20: 777–782.

    Article  CAS  Google Scholar 

  23. Krizek U . Serum uric acid in relation to body weight. Ann Rheum 1966; 25: 456–458.

    Article  CAS  Google Scholar 

  24. Juraschek SP, Miller ER 3rd, Gelber AC . Body mass index, obesity, and prevalent gout in the United States in 1988–1994 and 2007–2010. Arthritis Care Res (Hoboken) 2013; 65: 127–132.

    Article  Google Scholar 

  25. Tsushima Y, Nishizawa H, Tochino Y, Nakatsuji H, Sekimoto R, Nagao H et al. Uric acid secretion from adipose tissue and its increase in obesity. J Biol Chem 2013; 288: 27138–27149.

    Article  CAS  Google Scholar 

  26. Yamashita S, Matsuzawa Y, Tokunaga K, Fujioka S, Tarui S . Studies on the impaired metabolism of uric acid in obese subjects: Marked reduction of renal urate excretion and its improvement by a low-calorie diet. Int J Obes 1986; 10: 255–264.

    CAS  PubMed  Google Scholar 

  27. Stolarz-Skrzypek K, Bednarski A, Czarnecka D, Kawecka-Jaszcz K, Staessen JA . Sodium and potassium and the pathogenesis of hypertension. Curr Hypertens Rep 2013; 15: 122–130.

    Article  CAS  Google Scholar 

  28. Zhang Z, Cogswell ME, Gillespie C, Fang J, Loustalot F, Dai S et al. Association between usual sodium and potassium intake and blood pressure and hypertension among US adults: NHANES 2005-2010. PLoS ONE 2013; 8: e75289.

    Article  CAS  Google Scholar 

  29. Briasoulis A, Agarwal V, Messerli FH . Alcohol consumption and the risk of hypertension in men and women: a systematic review and meta-analysis. J Clin Hypertens (Greenwich) 2012; 14: 792–798.

    Article  Google Scholar 

  30. Jung JG, Kim JS, Kim YS, Oh MK, Yoon SJ . Hypertension associated with alcohol consumption based on the facial flushing reaction to drinking. Alcohol Clin Exp Res 2013; 38 (4): 1020–1025.

    Article  Google Scholar 

  31. Borghi C, Veronesi M, Bacchelli S, Esposti DD, Cosentino E, Ambrosioni E . Serum cholesterol levels, blood pressure response to stress and incidence of stable hypertension in young subjects with high normal blood pressure. J Hypertens 2004; 22: 265–272.

    Article  CAS  Google Scholar 

  32. Liu X, Wang K, Lee K . Association of standardized estimated glomerular filtration rate with the prevalence of hypertension among adults in the United States. J Hum Hypertens 2011; 25: 469–475.

    Article  CAS  Google Scholar 

  33. Zhu Y, Pandya BJ, Choi HK . Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63: 3136–3141.

    Article  Google Scholar 

  34. Feig DI, Soletsky B, Johnson RJ . Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. JAMA 2008; 300: 924–932.

    Article  CAS  Google Scholar 

  35. Whelton A . Hyperuricemia and hypertension: a confluence of concepts. Hypertension 2012; 60: 1112–1113.

    Article  CAS  Google Scholar 

  36. Gutiérrez-Macías A, Lizarralde-Palacios E, Martínez-Odriozola P, Miguel-De la Villa F . Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. BMJ 2005; 331: 623–624.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology, University of Nebraska Medical Center, Omaha, NE, USA

    G-M Han

  2. Nebraska Department of Health and Human Services, Lincoln, NE, USA

    G-M Han, S Gonzalez & D DeVries

  3. Department of Educational Psychology, University of Nebraska-Lincoln, Lincoln, NE, USA

    S Gonzalez

Authors
  1. G-M Han
    View author publications

    Search author on:PubMed Google Scholar

  2. S Gonzalez
    View author publications

    Search author on:PubMed Google Scholar

  3. D DeVries
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to G-M Han.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, GM., Gonzalez, S. & DeVries, D. Combined effect of hyperuricemia and overweight/obesity on the prevalence of hypertension among US adults: result from the National Health and Nutrition Examination Survey. J Hum Hypertens 28, 579–586 (2014). https://doi.org/10.1038/jhh.2014.31

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/jhh.2014.31

This article is cited by

Search

Advanced search

Quick links